Learn bits
Health & Medicine
Mahesh

07/09/22 13:51 PM IST

India's first intranasal Covid vaccine by Bharat Biotech gets DCGI approval

In News 
  • India's first intranasal Covid vaccine by Bharat Biotech received DCGI approval for primary immunization against the infection for people above the age of 18.
About Intranasal Vaccine 
  • The intranasal vaccine for COVID-19 by Bharat Biotech is first of its kind needle-free vaccine.
  • Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.
iNCOVACC
  • The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
  • This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results.
  • This vaccine has been specifically formulated to allow intranasal delivery through nasal drops.
  • The nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries.
  • The intranasal vaccine is a heterologous booster dose.
Source- Live Mint 

More Related Current Affairs View All

05 May

Key objectives of caste count

'The Union Cabinet has decided that the next Census will include questions on caste to its enumeration of India’s population, for the first time in almost a century. ' T

Read More

05 May

2 new genome-edited rice varieties

'Agriculture Minister Shivraj Singh Chouhan recently released two genome-edited varieties of rice, the first achievement of its kind in the country.' These two varieties, which

Read More

05 Mar

First-ever comprehensive survey of India’s river dolphins

'Prime Minister Narendra Modi released the results of the first-ever comprehensive population estimation of riverine dolphins – Gangetic and Indus dolphins – done in In

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps